Kotak Healthcare Fund - Growth - Regular Plan

Other Plans and Options
  • (-0.57%)Nav, as on 21-01-2026

  • Previous Nav

  • Net Change on 21-01-2026

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The investment objective of the scheme is to seek to generate long term capital appreciation throughinvesting in equity and equity related securities of companies benefitting directly or indirectly Pharma, Healthcare, and allied sectors.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A
Nifty Healthcare Index - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Nippon India Pharma Fund-Growth Plan-Growth Jun 05, 2004 -1.49 20.10 14.06 1.82 8,264.71
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option Jul 13, 2018 -1.13 25.33 16.15 1.86 6,455.55
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH Jul 14, 1999 -3.40 22.03 15.19 1.93 3,989.42
DSP Healthcare Fund - Regular Plan - Growth Nov 30, 2018 -7.40 19.82 14.15 1.92 3,114.33
Mirae Asset Healthcare Fund -Regular Growth Jul 02, 2018 -2.19 19.86 14.24 1.93 2,770.84

Fund Holdings as on 31-December-2025

  • SUN PHARMACEUTICAL INDUSTRIES LTD.

  • Max Healthcare Institute Ltd.

  • JB Chemicals & Pharmaceuticals Ltd.

  • Divis Laboratories Ltd.

  • Cipla Ltd.

  • Lupin Ltd.

  • Apollo Hospitals Enterprise Ltd.

  • Triparty Repo

  • Fortis Healthcare India Ltd

  • Ami Organics Ltd

  • JUBILANT PHARMOVA LIMITED

  • SAI LIFE SCIENCES LIMITED

  • Ajanta Pharma Ltd.

  • KRISHNA INSTITUTE OF MEDICAL

  • Alkem Laboratories Ltd.

  • Aurobindo Pharma Ltd.

  • PARK MEDI WORLD LIMITED (PARK HOSPITAL)

  • Gland Pharma Limited

  • ANTHEM BIOSCIENCES LTD

  • Glenmark Pharmaceuticals Ltd

  • Marksans Pharma Ltd

  • Dr.Reddy's Laboratories Ltd.

  • MANKIND PHARMA LTD

  • LAXMI DENTAL LIMITED

  • CORONA REMEDIES LIMITED

  • ORCHID PHARMA LIMITED

  • Zydus Lifesciences Ltd.

  • RUBICON RESEARCH LIMITED

  • YATHARTH HOSPITAL AND TRAUMA CARE SERVICES LTD

  • RAINBOW CHILDRENS MEDICARE LTD

  • INNOVA CAPTABS LTD

  • Krsnaa Diagnostics Ltd

  • Net Current Assets/(Liabilities)

View More

  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Miscellaneous

  • Medical Equipment/Supplies/Accessories

View More

Fund Manager

  • Cash

  • Equity

View More

About Kotak Healthcare Fund

Scheme Analysis

Kotak Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to Kotak Mahindra Mutual Fund. It was launched on 11-Dec-2023 and currently has an AUM of ₹467.92 crore. Kotak Healthcare Fund is benchmarked against NIFTY 50 - TRI as primary index and Nifty Healthcare Index - TRI as secondary index.

The NAV of Kotak Healthcare Fund ended down ₹-0.07(-0.57%)yesterday to ₹12.625.

Among its top 3 holdings the fund has exposure to SUN PHARMACEUTICAL INDUSTRIES LTD., and

The Kotak Healthcare Fund is managed by Abhishek Bisen and Shibani Kurian.

Fund House Contact

27 BKC, C-27, G Block, Bandra Kurla Complex, Bandra (E), Mumbai - 400 051

+91 (22) 66384400
mutual@kotak.com
+91 (22) 66384455